Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1599-1604, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1599-1604.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cysteine Protease Secreted by Paragonimus
westermani Attenuates Effector Functions of Human Eosinophils
Stimulated with Immunoglobulin G
Myeong Heon
Shin,1,2,*
Hirohito
Kita,3
Hae Young
Park,2,4 and
Ju
Young
Seoh2,5
Departments of
Parasitology,1
Biochemistry,4 and
Microbiology5 and Medical
Research Center,2 College of Medicine, Ewha
Woman's University, Seoul 158-710, Korea, and Department of
Immunology and Internal Medicine, Mayo Clinic and Mayo Foundation,
Rochester, Minnesota 559053
Received 27 September 2000/Returned for modification 1 December
2000/Accepted 15 December 2000
 |
ABSTRACT |
An immunoglobulin G (IgG)-coated surface, such as that found on
helminth parasites, is one of the most effective physiologic stimuli
for eosinophil activation. The cysteine proteases secreted by
tissue-invasive helminth larvae play an important role in evasion of
the immune response by degrading the host immunoglobulins. In this
study, we investigated whether cysteine proteases in the excretory-secretory product (ESP) produced by Paragonimus
westermani newly excysted metacercariae (PwNEM), which cause
pulmonary or extrapulmonary paragonimiasis in human beings, could
modify effector functions of human eosinophils stimulated with IgG. We
coated 96-well plates with human IgG in the absence or presence of the ESP produced by PwNEM. When eosinophils were incubated in the wells
coated with IgG in the presence of the ESP, eosinophil degranulation and superoxide production were significantly reduced compared with
results for cells incubated in wells coated with IgG alone. This
inhibitory effect of the ESP on IgG-induced superoxide production was
dose dependent and was significantly abolished by pretreatment of the
ESP with heat. These findings suggest that the cysteine proteases
secreted by PwNEM attenuate both activation and degranulation of
eosinophils stimulated with IgG. Thus, the cysteine proteases produced
by tissue-invasive helminth larvae play crucial roles in evasion of
IgG-dependent eosinophil helminthotoxicity and in reduction of
eosinophil-associated tissue inflammation during the migratory period.
 |
INTRODUCTION |
Eosinophils are known to be
important effector cells in the host defense against helminth parasites
(15). They can damage or kill helminth worms by
antibody-dependent cellular cytotoxicity mechanisms in in vitro
cultures (5, 12, 28). Although the exact mechanisms by
which eosinophils kill helminth parasites in vivo are not completely
understood, degranulation of adhering eosinophils has been suggested to
play a major role (13, 25). For example, eosinophil
granule proteins, such as major basic protein, eosinophil peroxidase,
and eosinophil cationic protein, directly damage a variety of helminth
parasites (6, 16, 22, 37). Once the eosinophil has
migrated into inflamed tissue in vivo, it becomes activated and
releases various mediators, such as reactive oxygen intermediates,
lipid mediators, and cytotoxic granular proteins (14).
Recently the activators and regulators of eosinophil functions have
been demonstrated. Several in vitro studies suggest that immobilized
immunoglobulin G (IgG) (21, 27), secretory IgA
(1), platelet-activating factor (24), and
cytokines, such as interleukin 5 (IL-5), IL-3, granulocyte-macrophage colony-stimulating factor, and RANTES (19), are effective
stimuli for activation of human eosinophils. Although the activated
eosinophils are clearly involved in the killing of the worms in vitro,
it is interesting to note that tissue-dwelling helminth parasites adapted for the human host can reinfect and/or survive for many years
even in the activation of the host immune responses. Therefore, tissue-invading helminthic worms may have an immune escape mechanism of
down-regulation of eosinophil effector functions, thus enabling the
worm to pass through host immune defenses unmolested.
Excretory-secretory products (ESP) produced by tissue-invasive helminth
larvae contain a large quantity of proteolytic enzymes, which are
essential for worm maturation (35), migration in host tissues (29), and modulation of the immune response
(3, 7, 8, 23). In vitro cleavage of IgG by cysteine
proteases in the ESP secreted by tissue-invasive helminth larvae has
been correlated with immune escape from antibody-dependent cellular
toxicity. For example, cysteine proteases produced by Paragonimus
westermani newly excysted metacercariae (PwNEM) are capable of
degrading host IgG in vitro (8). Cysteine proteases of
invasive larvae of other helminths, such as Fasciola
hepatica (3) or Spirometra mansoni
(23), have also been known to cleave IgG molecules. Moreover, cysteine proteases secreted by F. hepatica in
vitro prevent parasite-specific antibody-mediated eosinophil attachment to newly excysted juvenile worms (7). Therefore, these
findings led us to speculate that cysteine protease secreted by the
tissue-invasive helminth parasites may modify the effector functions of
eosinophils in the presence of parasite-specific IgG.
Freshly isolated eosinophils express only Fc
RII (18),
and eosinophil activation induced by immobilized IgG is mediated through Fc
RII (20). IgG bound to Sepharose beads
(1) or IgG applied to tissue culture plates
(21) triggers degranulation and superoxide production of
human eosinophils. In contrast to these responses of eosinophils to
solid-phase IgG, little is known regarding the roles of
parasite-secreted cysteine proteases that might alter the effector
functions of eosinophils stimulated with IgG. The understanding of
mechanisms used by cysteine proteases secreted by the PwNEM to moderate
IgG-induced effector functions of eosinophils provides a key clue that
eosinophils may not serve as strong effector cells in tissue helminth
infections. To prove this hypothesis, we investigated whether cysteine
proteases released by the PwNEM, which cause pulmonary or
extrapulmonary paragonimiasis in human beings, could attenuate
degranulation and superoxide production of eosinophils stimulated with IgG.
 |
MATERIALS AND METHODS |
Preparation of ESP produced by PwNEM.
Metacercariae of
P. westermani were collected from naturally infected
freshwater crayfish, Cambaroides similis, in an area of
endemicity in Korea (32). The soft tissues of crayfish,
crushed in a mortar, were emulsified in physiological saline and
filtered through a mesh screen, and the sediment was examined under a
dissecting microscope. Crude ESP of P. westermani
metacercariae was prepared by transferring 5,000 newly excysted
metacercariae into 5 ml of physiological saline and incubating at
37°C in a 5% CO2 incubator for 12 h. The incubation
medium was dialyzed against distilled water and centrifuged at
1,700 × g for 30 min. The resulting supernatant was
lyophilized and diluted with an appropriate medium to the desired
concentration immediately before use. The amounts of proteins in the
ESP were measured using the bicinchoninic acid protein assay kit
(Pierce, Rockford, Ill.). The ESP was analyzed by sodium dodecyl
sulfate-7.5 to 15% polyacrylamide gel electrophoresis (SDS-7.5 to
15% PAGE), with a 0.125% (wt/vol) Coomassie blue stain. In some
experiments, to examine the relation between the number of PwNEM and
protein amounts contained in the ESP secreted by PwNEM, 10, 30, 100, 200, and 300 newly excysted metacercariae were cultured in 48 wells of
tissue culture plates for 12 h at 37°C in a 5%-CO2
incubator. After incubation, the culture supernatant was collected for
measurement of protein concentrations contained in the ESP. The protein
concentrations in the ESP produced by PwNEM were linear between the
numbers of 10 and 300 larvae as determined by a standard curve
(r2 = 0.937). Two, six, and twenty
micrograms of ESP used in this study are equivalent to amounts produced
by 9, 36, and 130 excysted metacercariae, respectively.
IgG cleavage assay by the ESP.
Twenty-five microliters of
human whole IgG (Sigma, St. Louis, Mo.) diluted at a concentration of
200 µg/ml in phosphate-buffered saline (PBS) were mixed with same
volume of the ESP containing 2, 6, and 20 µg of protein or PBS. The
mixtures were incubated for 90 min at 37°C, and then the reactants
were subjected to SDS-12.5% PAGE. Proteins were electrotransferred to
a nitrocellulose membrane. The membrane was then incubated with
horseradish peroxidase-conjugated goat anti-human whole IgG
(1:1,000 dilution; Sigma) for 3 h at room temperature
(RT). The membranes were developed using 4-chloro-1-naphthol (Sigma)
solution to visualize degradative products of IgG.
Preparation of IgG-coated wells in the absence or presence of the
ESP.
The 96-well tissue culture plates were coated with human IgG,
50 µl, diluted in PBS at three concentrations (10, 30, and 100 µg/ml) in the absence or presence of ESP (2, 6, or 20 µg) for 2 h at 37°C. After 2 h of incubation, the wells were aspirated and washed twice with PBS. In some experiments, the ESP was pretreated with heat for 30 min at 56°C or cysteine protease inhibitor E-64 (Boehringer Mannheim Biochemicals, Mannheim, Germany). In brief, 12.5 µl of ESP (10 µg) diluted in PBS was allowed to react with same
volume of E-64 diluted in PBS (final concentration, 5 or 10 µM) for
1 h at RT. The heat- or E-64-treated ESP were mixed with 25 µl
of IgG (200 µg/ml) diluted in PBS, 50 µl of the total mixtures was
added to wells of 96-well tissue culture plates, and then the plates
were incubated for 2 h at 37°C. After incubation, the wells were
aspirated and washed twice with 200 µl of PBS before use.
Isolation of peripheral blood eosinophils.
Eosinophils were
isolated from the peripheral blood of normal volunteers using a
magnetic cell separation system (Miltenyi Biotec, Bergisch Gladbach,
Germany), as described previously (17), with minor
modifications. In brief, venous blood (30 ml) anticoagulated with 10 U
of heparin/ml was diluted with
piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES) buffer
(25 mM PIPES, 50 mM NaCl, 5 mM KCl, 25 mM NaOH, 5.4 mM glucose [pH
7.4]) at a 1:1 ratio. Diluted blood was overlayered on a Histopaque
solution (density, 1.083 g/ml) (Sigma) and centrifuged at
100 × g for at 4°C for 30 min. The supernatant and
mononuclear cells at the interface were removed carefully. The inside
wall of the centrifuge tube was wiped twice with sterile gauze to
eliminate mononuclear cells adhering to the walls. Erythrocytes in the
sediment were lysed by exposure to two cycles of sterile distilled
water. Isolated granulocytes were washed with PIPES buffer containing
1% fetal bovine serum (Gibco, Grand Island, N.Y.), and an
approximately equal volume of anti-CD16 antibody (Ab) conjugated with
magnetic particles (Miltenyi Biotec) was added to the cell pellet.
After 30 min of incubation on ice, cells were loaded onto the
separation column positioned in the magnetic cell separation system
magnetic field. Cells were eluted with 15 ml of PIPES buffer with 1%
fetal bovine serum. The purity of eosinophils counted by Randolph's
stain was >95%. The contaminating cells were neutrophils, and no
mononuclear cells or basophils were present. Purified eosinophils were
used immediately for experiments.
Assay for eosinophil degranulation.
Freshly purified
eosinophils were suspended in Hanks balanced salt solution (pH 7.4;
Gibco) supplemented with 10 mM HEPES (Sigma) and 0.03% gelatin (Sigma)
at a concentration of 2.5 × 105 cells/ml.
Two-hundred-microliter aliquots of cell suspension were added to the
wells coated with IgG in the absence or presence of the ESP. For the
experiments on eosinophil degranulation, the cells were incubated for
3 h in a humidified incubator at 37°C and 5% CO2.
After incubation, supernatants were collected and frozen at
20°C
until they were assayed for eosinophil-derived neurotoxin (EDN), as
described below.
Assay for EDN.
To quantitate eosinophil degranulation, EDN
concentrations in the culture supernatants were measured by
radioimmunoassay (RIA), as described previously (1). The
RIA is a double Ab competition assay using radioiodinated EDN, rabbit
anti-EDN Ab, and burro anti-rabbit IgG. All assays were performed in duplicate.
Superoxide anion generation.
Two hundred microliters of cell
suspension (2.5 × 105 cell/ml) in Hanks balanced salt
solution with 10 mM HEPES, 0.03% gelatin, and 100 µM cytochrome
c (Sigma) were dispensed in the wells coated with IgG in the
absence or presence of the ESP. In some experiments, 200 µl of cell
suspension was added to wells coated with IgG in the presence of heat-
or E-64-treated ESP or PBS-treated ESP. Immediately after the addition
of the cells, the absorbance at 550 nm in each well was measured with a
microplate autoreader (Thermomax; Molecular Devices, Sunnyvale,
Calif.), followed by repeated readings. Between absorbance
measurements, the plate was incubated at 37°C. Each reaction was
conducted in duplicate, and superoxide anion generation was calculated
with an extinction coefficient of 21.1 × 10
3 M/cm
for reduced cytochrome c at 550 nm and was expressed as nanomoles of cytochrome c reduction/105 cells.
Statistical analysis.
Statistical significance of difference
between the control and treatment groups was assessed with the unpaired
Student's t test. Probability values of less than 0.05 or
0.01 were considered significant.
 |
RESULTS |
Cleavage effects of ESP produced by PwNEM on human IgG in
vitro.
As shown in Fig. 1A, the ESP
produced by PwNEM contains two protein bands consisting of two cysteine
proteases, 28 and 27 kDa in molecular mass, as previously reported
(10). To know what amount of the ESP is required to
degrade human IgG, three different doses of the ESP (2, 6, and 20 µg)
were mixed with IgG diluted in PBS at a concentration of 100 µg/ml.
As shown in Fig. 1B, the ESP cleaved IgG in a dose-dependent manner.
Six or twenty micrograms of ESP apparently degraded heavy and light
chains of IgG. In contrast, no evident cleavage of IgG by 2 µg of the
ESP was shown, although a degradation product of the heavy chain of IgG
was faintly observed.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
Electrophoretic analysis of crude ESP produced by
PwNEM and immunoblot analysis for IgG cleavage by the ESP. (A)
SDS-7.5 to 15% PAGE of the crude ESP. The protein bands at 28 and 27 kDa in molecular mass are cysteine proteases. (B) Cleavage pattern of
human IgG induced by the ESP. Three different amounts (2, 6, and 20 µg at lanes 1, 2, and 3, respectively) of the ESP were incubated with
human IgG solution (100 µg/ml) for 90 min at 37°C. After
incubation, the reactants were separated by SDS-12.5% PAGE,
transferred to a nitrocellulose membrane, and probed with anti-human
IgG (whole molecule). A degradation product of heavy chain at 32 kDa
(arrow) was first detected. The symbols and indicate heavy and
light chains of IgG, respectively. Lane C, control IgG.
|
|
Effects of cysteine proteases secreted by PwNEM on degranulation of
eosinophils stimulated with IgG.
To investigate the effects of
cysteine proteases secreted by PwNEM on IgG-induced eosinophil
degranulation, eosinophils were incubated in the wells coated with
human IgG in the absence or presence of the ESP produced by PwNEM.
Table 1 shows degranulation of
eosinophils stimulated with immobilized IgG alone. The amount of
released EDN was dependent on the concentration of IgG used to coat the
wells. When eosinophils were incubated in wells coated with 10, 30, and
100 µg of IgG/ml, EDN release (mean ± the standard error of the
mean [SEM]) was 183 ± 86.0, 220 ± 85.2, and 315 ± 106.4 ng/106 cells, respectively. EDN release was about 100 ± 35.6 ng/106 cells when the wells were not coated with
IgG. In contrast, when eosinophils were incubated in wells coated with
IgG (100 µg/ml) in the presence of the ESP, eosinophil degranulation
was reduced about 50% from that of cells incubated in wells coated
with IgG alone (Fig. 2). At the same
time, we also compared morphologic changes of eosinophils incubated in
wells coated with IgG in the absence or presence of the ESP. Most of
the eosinophils incubated in the wells coated with IgG alone were fully
activated to show an extensive degranulative state, whereas eosinophils
cultured in the wells coated with IgG in the presence of the ESP were
generally oval and elongated (data not shown). Eosinophils cultured in
uncoated plates were spherical and refractile.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Effects of ESP produced by PwNEM on IgG-induced
eosinophil degranulation. Wells were coated with 100 µg of IgG/ml in
the absence or presence of the ESP at the doses indicated for 2 h
at 37°C. After washing, eosinophils were added to the wells and
incubated for 3 h at 37°C. Data are normalized to the mean
degranulation of eosinophils incubated in the wells coated with IgG
alone, taken as 100% (control values [mean ± SEM], 315 ± 106.4 ng/106 cells). Data are presented as the mean ± SEM from three independent experiments performed in duplicate.
Significant differences from the control are as follows: asterisk,
P < 0.05; double asterisk, P < 0.01.
|
|
Effects of cysteine proteases secreted by PwNEM on superoxide
production of eosinophils stimulated with IgG.
To determine the
effects of cysteine proteases secreted by PwNEM on IgG-induced
eosinophil superoxide production, eosinophils were incubated in the
wells coated with human IgG in the absence or presence of the ESP
produced by PwNEM. Figure 3 shows that eosinophils stimulated with 10, 30, and 100 µg of IgG/ml produced superoxide, which is detectable after 90 (1.5 ± 0.18 nmol), 60 (1.5 ± 0.26 nmol), and 45 (1.7 ± 0.36 nmol) min, respectively, and increasingly gradually thereafter. In contrast, superoxide production was strongly decreased when the cells were incubated in the
wells coated with IgG in the presence of the ESP (Fig. 3). Consistent
with the results of IgG cleavage by the ESP (Fig. 1B), the inhibitory
effect of the ESP on IgG-induced eosinophil superoxide production
occurred in a dose-dependent fashion.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of superoxide anion production by eosinophils
incubated in the wells coated with IgG in the absence or presence of
ESP produced by PwNEM. Wells were coated with IgG (top panel, 10 µg/ml; middle panel, 30 µg/ml; bottom panel, 100 µg/ml) in the
absence or presence of the ESP at the doses indicated for 2 h at
37°C. After washing, eosinophils were added to the wells, and
superoxide production from eosinophils was measured by superoxide
dismutase-inhibitable reduction of cytochrome c, as
described in Materials and Methods. Data are shown as nanomoles of
cytochrome c reduced/105 cells. The results
represent mean values from four independent experiments performed in
duplicate.
|
|
To confirm whether the inhibitory effect of the ESP on superoxide
production of eosinophils stimulated with IgG was due to
degradation of
IgG by cysteine proteases in the ESP, the ESP was
pretreated with heat
or cysteine protease inhibitor E-64 before
reaction with IgG. As shown
in Fig.
4, the inhibitory effect of
the
ESP on IgG-induced superoxide production was partially blocked
by
pretreatment of the ESP with heat or E-64. However, pretreatment
of
heat significantly (
P < 0.05) prevented the inhibitory
effect
of the ESP on IgG-induced superoxide production.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of heat-treated or cysteine protease inhibitor
(E-64)-treated ESP on IgG-induced superoxide production. The ESP (10 µg) was pretreated with heat for 30 min at 56°C or with E-64 at the
concentrations indicated for 1 h at RT, and tissue culture plates
were coated with IgG (100 µg/ml) in the presence of heat- or
E-64-treated ESP for 2 h at 37°C. After aspiration of the
solution in the wells, eosinophils were added to the wells and
incubated for 180 min at 37°C. Data are normalized to the mean
superoxide production (nanomoles of cytochrome c
reduced/105 cells) induced by IgG alone, taken as 100%
(control; 6.2 ± 0.29 nmol). Data are presented as the mean ± SEM from three independent experiments performed in duplicate.
Significant differences from results for PBS-treated ESP are indicated
by an asterisk (P < 0.05). The lack of E-64 at the
concentrations tested in this experiment had detectable effects on
eosinophil superoxide production.
|
|
 |
DISCUSSION |
This study demonstrates that the cysteine proteases secreted by
PwNEM play an important role in attenuation of the effector function of
eosinophils stimulated with IgG. The ESP produced by PwNEM, which
consists of two cysteine proteases (Fig. 1A), cleaved whole human IgG
molecules in a dose-dependent manner in vitro (Fig. 1B). When
eosinophils were incubated in the wells coated with IgG in the presence
of the ESP, eosinophil degranulation was significantly inhibited
compared with results for cells incubated in the wells coated with IgG
alone (Fig. 2). This inhibitory effect of the ESP on IgG-induced
eosinophil degranulation was well correlated with the morphologic
changes of eosinophils incubated in wells coated with IgG in the
presence of the ESP (data not shown). In addition, when the cells were
incubated in wells coated with IgG in the presence of the ESP,
superoxide production of eosinophils was dose-dependently inhibited
compared with results for cells cultured in the wells coated with IgG
alone (Fig. 3). Furthermore, this inhibitory effect of the ESP on
IgG-induced superoxide production was partially abolished by
pretreatment of the ESP with heat or E-64 (Fig. 4). However, treatment
with heat inhibited the action of the ESP more potently than that with
E-64 did. These results suggest that cysteine proteases secreted by
PwNEM inhibit activation of eosinophils stimulated with IgG. Taken
together, our findings indicate that the cysteine protease secreted by
PwNEM moderates the eosinophil's responses to the parasite-specific
IgG-coated surface of the larva, resulting in reduced generation of
superoxide and diminished degranulation.
In this study, the inhibitory effect of the ESP on eosinophil
degranulation was somewhat different from that on superoxide production. For example, the smallest amounts of EDN were released when
eosinophils were incubated in the wells coated with IgG (100 µg/ml)
in the presence of the lowest dose (2 µg) of the ESP (Fig. 2). This
finding is not consistent with the result that the smallest amount of
superoxide was produced when cells were cultured in the wells coated
with IgG in the presence of the highest dose (20 µg) of the ESP (Fig.
3). The lowest dose of the ESP tested in this study was equivalent to
the amounts of proteins produced by nine excysted metacercariae of
P. westermani. Therefore, it is suggested that the release
of low doses of the ESP secreted by small numbers of PwNEM into host
tissues is enough to suppress eosinophil degranulation stimulated with
IgG, although the capability of low doses of the ESP for cleaving the
IgG is minimal in vitro.
It is likely that following tight attachment of eosinophils to
IgG-coated worms, the release of EDN may restrict motility of the
larvae, thereby preventing the process of shedding of surface antigen
and allowing adhering eosinophils to kill the worms by the release of
eosinophil-toxic granules (16). On the other hand,
actively motile larvae shrink their bodies to decrease their surface
area in contact with antibody (28). In addition, the ESP,
consisting of two cysteine proteases that are produced by PwNEM,
induced a direct time- and concentration-dependent increase in the rate
of constitutive apoptosis in mature human eosinophils (31). Annexin-V-positive cells were first apparent 3 h after treatment with the ESP and continued to increase after 6 h
of incubation. While only 2.8% of the eosinophils incubated in the medium for 3 h were apoptotic, 7.6, 10.9, and 22.6% of the
eosinophils treated with 10, 30, and 100 µg of ESP/ml were apoptotic,
respectively. Moreover, treatment of human eosinophils with lower
concentrations (0.3 and 1 µg/ml) of the ESP secreted by the PwNEM
induced IL-8 production, whereas treatment of the cells with higher
concentrations (3 and 10 µg/ml) did not (33). These
inhibitory effects of the higher doses of the ESP on IL-8 production
were completely abolished by pretreatment of the ESP with heat, and the
amount of IL-8 released into culture supernatants was inversely
correlated with the rate of eosinophil survival. These findings
strongly suggest that the high amount and proteolytic activity of the
cysteine proteases secreted by the metacercarial larvae (8,
9) allow the larvae to establish silent migration or residence
in their hosts without provoking eosinophil-mediated tissue
hypersensitivity reactions during the migratory periods. This
suggestion confirms recent findings that eosinophils cannot serve as
strong effector cells against tissue helminth parasites in vivo
(4, 11, 26, 30).
P. westermani is a lung fluke, which mainly dwells in lung
parenchyme in a final host, including humans. Ingested metacercarial larvae excyst in the duodenum by the release of two endogenous cysteine
proteases of 27 and 28 kDa in molecular mass (10), and the
larva-secreted cysteine proteases pave the way for their safe migration
from the intestines to the lungs during the migratory phase. The 27-kDa
cysteine protease in the ESP was similar to Fasciola
hepatica cathepsin L (7) or sparganum cathepsin S (23) in terms of substrate specificity for Cbz-Phe-Arg-MNA
and stability at a neutral pH. On the other hand, the 28-kDa protease shared mammalian cathepsin B-like properties (2) with
respect to its molecular mass, selective cleavage of
Cbz-Ala-Arg-Arg-MNA, and relatively low activity at pH 7.5. Therefore,
the in vivo role of each protease contained in the metacercarial ESP in
the behavior of eosinophils may be different. In this regard, it would be interesting to compare the effects of each protease purified from
ESP on effector functions of eosinophils.
Until now, at least five species of the cysteine proteases of P. westermani have been identified. For example, 28- and 27-kDa enzymes from the metacercarial larvae (10, 36), 15- and
53-kDa enzymes from the juveniles and adults (9), and
17-kDa cysteine proteases from the adults (34) have been
purified. Of the five cysteine proteases, two cysteine proteases from
the metacercarial larvae reveal higher levels of proteolytic activity
in cleavage of IgG than the others from juveniles and adult worms of
P. westermani (8). Furthermore, the amounts of
the two cysteine proteases from the metacercariae are dramatically
lowered as the worms mature in vivo (9). Thus, different
cysteine protease activities in cleaving human IgG during maturation
stages of P. westermani may be responsible for the
differences in the resident site of the worms during the infection.
In summary, we report that cysteine protease in the ESP produced by
newly excysted P. westermani metacercariae plays a crucial role in attenuating effector functions of eosinophils stimulated with
IgG. Further studies focused on other biological roles of the cysteine
proteases secreted by newly excysted P. westermani metacercariae in behaviors of eosinophils will help us to understand their pathophysiological roles in relation to eosinophil-associated tissue inflammation in helminth parasitic diseases.
 |
ACKNOWLEDGMENTS |
We thank Yong-Moo Won, Department of Parasitology, College of
Medicine, Ewha Woman's University, for his sincere help in collecting freshwater crayfish and isolating P. westermani
metacercariae from the crayfish.
This research was supported by the MOST through the National Research
Program (00-N6-01-01-A-05) for Woman's University.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Parasitology, College of Medicine, Ewha Woman's University, 911-1, Mok-6-Dong, Yangcheon-Gu, Seoul 158-710, Korea. Phone: 82-2-650-5750. Fax: 82-2-653-8891. E-mail: mhshin{at}mm.ewha.ac.kr.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Abu-Ghazaleh, R. I.,
T. Fujisawa,
J. Mestecky,
R. A. Kyle, and G. J. Gleich.
1989.
IgA-induced eosinophil degranulation.
J. Immunol.
142:2393-2400[Abstract].
|
| 2.
|
Barrett, A. J., and H. Kirschke.
1981.
Cathepsin B, cathepsin H, and cathepsin L.
Methods Enzymol.
80:535-561.
|
| 3.
|
Berasain, P.,
C. Carmona,
B. Frangione,
J. P. Dalton, and F. Goni.
2000.
Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced.
Exp. Parasitol.
94:99-110[CrossRef][Medline].
|
| 4.
|
Brunet, L. R.,
E. A. Sabin,
A. W. Cheever,
M. A. Kopf, and E. J. Pearce.
1999.
Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells.
Infect. Immun.
67:3014-3018[Abstract/Free Full Text].
|
| 5.
|
Butterworth, A. E.,
R. F. Sturrock,
V. Houba,
A. A. F. Mahmoud,
A. Sher, and P. H. Rees.
1975.
Eosinophils as mediators of antibody-dependent damage to schistosomula.
Nature
256:727-729[CrossRef][Medline].
|
| 6.
|
Butterworth, A. E.,
D. L. Wassom,
G. J. Gleich,
D. A. Loegering, and J. R. David.
1979.
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic proteins.
J. Immunol.
122:221-229[Abstract/Free Full Text].
|
| 7.
|
Carmona, C.,
A. J. Dowd,
A. M. Smith, and J. P. Dalton.
1993.
Cathepsin L proteinases secreted by Fasciola hepatica in vitro prevent antibody-mediated eosinophil attachment to newly excysted juveniles.
Mol. Biochem. Parasitol.
62:9-17[CrossRef][Medline].
|
| 8.
|
Chung, Y. B.,
H. J. Yang,
S. Y. Kang,
Y. Kong, and S. Y. Cho.
1997.
Activities of different cysteine proteases of Paragonimus westermani in cleaving human IgG.
Korean J. Parasitol.
35:139-142[Medline].
|
| 9.
|
Chung, Y. B.,
Y. Kong,
H. J. Yang,
S. Y. Kang, and S. Y. Cho.
1997.
Cysteine protease activities during maturation stages of Paragonimus westermani.
J. Parasitol.
83:902-907[CrossRef][Medline].
|
| 10.
|
Chung, Y. B.,
Y. Kong,
I. J. Joo,
S. Y. Cho, and S. Y. Kang.
1995.
Excystment of Paragonimus westermani metacercariae by endogenous cysteine protease.
J. Parasitol.
81:137-142[CrossRef][Medline].
|
| 11.
|
Dent, L. A.,
C. M. Daly,
G. Mayrhofer,
T. Zimmerman,
A. Hallett,
L. P. Bignold,
J. Creaney, and J. C. Parsons.
1999.
Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis.
Infect. Immun.
67:989-993[Abstract/Free Full Text].
|
| 12.
|
Gansmuller, A.,
A. Anteunis,
S. M. Venturiello,
F. Bruschi, and R. A. Binaghi.
1987.
Antibody-dependent in vitro cytotoxicity of newborn Trichinella spiralis larvae: nature of the cells involved.
Parasite Immunol.
9:281-292[Medline].
|
| 13.
|
Glaert, A. M.,
D. A. Lammas, and W. P. H. Duffus.
1985.
Ultrastructural observations on the interaction between bovine eosinophils and juvenile Fasciola hepatica.
Parasitology
91:459-470.
|
| 14.
|
Gleich, G. J.
2000.
Mechanisms of eosinophil-associated inflammation.
J. Allergy Clin. Immunol.
105:651-663[CrossRef][Medline].
|
| 15.
|
Gleich, G. J., and C. R. Adolphson.
1986.
The eosinophilic leukocytes: structure and functions.
Adv. Immunol.
39:177-253[Medline].
|
| 16.
|
Hamann, K. J.,
R. L. Barker,
D. A. Loegering, and G. J. Gleich.
1987.
Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
J. Parasitol.
73:523-529[CrossRef][Medline].
|
| 17.
|
Hansel, T. T.,
I. J. M. de Vries,
T. Iff,
S. Rihs,
M. Wandzilak,
S. Betz,
K. Blaser, and C. Walker.
1991.
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.
J. Immunol.
145:105-110.
|
| 18.
|
Hartnell, A.,
R. Moqbel,
G. M. Walsh,
B. Bradley, and A. B. Kay.
1990.
Fc and CD11/CD18 receptor expression on normal density and low density human eosinophils.
Immunology
69:264-270[Medline].
|
| 19.
|
Horie, S.,
G. J. Gleich, and H. Kita.
1996.
Cytokines directly induce degranulation and superoxide production from human eosinophils.
J. Allergy Clin. Immunol.
98:371-381[CrossRef][Medline].
|
| 20.
|
Kaneko, M.,
M. C. Swanson,
G. J. Gleich, and H. Kita.
1995.
Allergen-specific IgG1 and IgG3 through Fc RII induce eosinophil degranulation.
J. Clin. Investig.
95:2813-2821.
|
| 21.
|
Kaneko, M.,
S. Horie,
M. Kato,
G. J. Gleich, and H. Kita.
1995.
A crucial role for 2 integrin in the activation of eosinophils stimulated by IgG.
J. Immunol.
155:2631-2641[Abstract].
|
| 22.
|
Kephart, G. G.,
G. J. Gleich,
D. H. Connor,
D. W. Gibson, and S. J. Ackerman.
1984.
Deposition of eosinophil granule major basic protein onto microfilaria of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine.
Lab. Investig.
50:51-61[Medline].
|
| 23.
|
Kong, Y.,
Y. B. Chung,
S. Y. Cho, and S. Y. Kang.
1994.
Cleavage of immunoglobulin G by excretory-secretory cathepsin S-like protease of Spirometra mansoni plerocercoid.
Parasitology
109:611-621.
|
| 24.
|
Kroegel, C.,
T. Yukawa,
G. Dent,
P. Venge,
K. F. Chung, and P. J. Barnes.
1989.
Stimulation of degranulation from human eosinophils by platelet activating factor.
J. Immunol.
142:3518-3526[Abstract].
|
| 25.
|
McLaren, D. J.,
C. D. Mackenzie, and F. J. Ramalho-Pinto.
1977.
Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasite helminths (Schistosoma mansoni, Trichinella spiralis, and Nippostrongylus brasiliensis).
Clin. Exp. Immunol.
30:105-118[Medline].
|
| 26.
|
Meeusen, E. N., and A. Balic.
2000.
Do eosinophils have a role in the killing of helminth parasites?
Parasitol. Today
16:95-101[CrossRef][Medline].
|
| 27.
|
Moqbel, R.,
A. J. MacDonald,
O. Cromwell, and A. B. Kay.
1990.
Release of leukotriene C4, LTC4, from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
Immunology
69:435-442[Medline].
|
| 28.
|
Rainbird, M. A.,
D. Macmillan, and E. N. T. Meeusen.
1998.
Eosinophil-mediated killing of Haemonchus contortus larvae: effect of eosinophil activation and role of antibody, complement and interleukin-5.
Parasite Immunol.
20:93-103[Medline].
|
| 29.
|
Rhoads, M. L., and R. H. Fetterer.
1997.
Extracellular matrix: a tool for defining the extracorporeal functions of parasite proteases.
Parasitol. Today
13:119-122[Medline].
|
| 30.
|
Sher, A.,
R. L. Coffman,
S. Hiney, and A. W. Cheever.
1990.
Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse.
J. Immunol.
145:3911-3916[Abstract].
|
| 31.
|
Shin, M. H.
2000.
Excretory-secretory product of newly excysted metacercariae of Paragonimus westermani directly induces eosinophil apoptosis.
Korean J. Parasitol.
38:17-23[Medline].
|
| 32.
|
Shin, M. H., and D. Y. Min.
1999.
Infection status of Paragonimus westermani metacercariae in crayfish (Cambaroides similis) collected from Bogildo (Islet), Wando-gun, Chollanam-do, Korea.
Korean J. Parasitol.
37:55-57[Medline].
|
| 33.
|
Shin, M. H., and S. Y. Lee.
2000.
Proteolytic activity of cysteine protease in excretory-secretory product of Paragonimus westermani newly excysted metacercariae pivotally regulates IL-8 production of human eosinophils.
Parasite Immunol.
22:529-533[CrossRef][Medline].
|
| 34.
|
Song, C. Y., and T. S. Kim.
1994.
Characterization of cysteine proteases from adult worms of Paragonimus westermani.
Korean J. Parasitol.
32:231-241[Medline].
|
| 35.
|
Wasilewski, M. M.,
K. C. Lim,
J. Phillips, and J. H. McKerrow.
1996.
Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo.
Mol. Biochem. Parasitol.
81:179-189[CrossRef][Medline].
|
| 36.
|
Yamakami, K., and F. Hamajima.
1987.
Purification and properties of a neutral thiol protease from larval trematode Paragonimus westermani.
Comp. Biochem. Physiol. B
87:643-648[Medline].
|
| 37.
|
Yoshimura, K.,
K. Uchida,
K. Sato, and H. Oya.
1984.
Ultrastructural evidence of eosinophil-mediated destruction of Angiostrongylus cantonensis transferred into the pulmonary artery of non-permissive hosts.
Parasite Immunol.
6:105-118[Medline].
|
Infection and Immunity, March 2001, p. 1599-1604, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1599-1604.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Procop, G. W.
(2009). North American Paragonimiasis (Caused by Paragonimus kellicotti) in the Context of Global Paragonimiasis. Clin. Microbiol. Rev.
22: 415-446
[Abstract]
[Full Text]
-
Collin, M., Olsen, A.
(2003). Extracellular Enzymes with Immunomodulating Activities: Variations on a Theme in Streptococcus pyogenes. Infect. Immun.
71: 2983-2992
[Full Text]
-
Collin, M., Svensson, M. D., Sjoholm, A. G., Jensenius, J. C., Sjobring, U., Olsen, A.
(2002). EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis. Infect. Immun.
70: 6646-6651
[Abstract]
[Full Text]
-
Collin, M., Olsen, A.
(2001). Effect of SpeB and EndoS from Streptococcus pyogenes on Human Immunoglobulins. Infect. Immun.
69: 7187-7189
[Abstract]
[Full Text]